168 related articles for article (PubMed ID: 2661597)
1. Classification of antiarrhythmic drugs.
Frumin H; Kerin NZ; Rubenfire M
J Clin Pharmacol; 1989 May; 29(5):387-94. PubMed ID: 2661597
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic agents and proarrhythmia.
Chaudhry GM; Haffajee CI
Crit Care Med; 2000 Oct; 28(10 Suppl):N158-64. PubMed ID: 11055685
[TBL] [Abstract][Full Text] [Related]
3. Classification and mechanism of action of antiarrhythmic drugs.
Scholz H
Fundam Clin Pharmacol; 1994; 8(5):385-90. PubMed ID: 7875632
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring: antiarrhythmic drugs.
Campbell TJ; Williams KM
Br J Clin Pharmacol; 1998 Oct; 46(4):307-19. PubMed ID: 9803978
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring: antiarrhythmic drugs.
Campbell TJ; Williams KM
Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):21S-34S. PubMed ID: 11564050
[TBL] [Abstract][Full Text] [Related]
6. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions.
Nattel S; Singh BN
Am J Cardiol; 1999 Nov; 84(9A):11R-19R. PubMed ID: 10568655
[TBL] [Abstract][Full Text] [Related]
7. Modernized Classification of Cardiac Antiarrhythmic Drugs.
Lei M; Wu L; Terrar DA; Huang CL
Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
[TBL] [Abstract][Full Text] [Related]
8. [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
Bjørnstad H; Refsum H
Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3187-9. PubMed ID: 1658976
[TBL] [Abstract][Full Text] [Related]
9. [Vaughan Williams class IV antiarrhythmic drugs].
Horie M; Washizuka T; Ikeguchi S; Sasayama S
Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788
[TBL] [Abstract][Full Text] [Related]
10. [Current classification of anti-arrhythmia agents].
Weirich J; Wenzel W
Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
[TBL] [Abstract][Full Text] [Related]
11. New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs.
Adams HR
J Am Vet Med Assoc; 1986 Sep; 189(5):525-32. PubMed ID: 2875984
[TBL] [Abstract][Full Text] [Related]
12. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
Antoni H; Weirich J
Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
[TBL] [Abstract][Full Text] [Related]
13. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
Ravens U
Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
[TBL] [Abstract][Full Text] [Related]
14. Comparative mechanisms of action of antiarrhythmic drugs.
Nattel S
Am J Cardiol; 1993 Nov; 72(16):13F-17F. PubMed ID: 8237825
[TBL] [Abstract][Full Text] [Related]
15. Class I or class III agents for atrial fibrillation: are asking the right question?
Pacifico A; Henry PD
Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 2):1613-9. PubMed ID: 12914611
[TBL] [Abstract][Full Text] [Related]
16. A benefit-risk assessment of class III antiarrhythmic agents.
Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
[TBL] [Abstract][Full Text] [Related]
17. [Classification and mechanism of action of anti-arrhythmia drugs].
Gasic S
Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324
[TBL] [Abstract][Full Text] [Related]
18. An "autonomic" classification of antiarrhythmic drugs.
Goldberger AL; Curtis GP
J Electrocardiol; 1982 Oct; 15(4):397-400. PubMed ID: 7142876
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of new insights into mechanism of antiarrhythmic drug action.
Meinertz T
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S23-7. PubMed ID: 1279305
[TBL] [Abstract][Full Text] [Related]
20. Oral antiarrhythmic agents for ventricular arrhythmias.
Meissner MD; Nestico PF; Morganroth J
Clin Ther; 1986; 8(6):595-604. PubMed ID: 3539346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
